JACLYN GUTIERREZ: Open Payments
NPI 1578288189 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 20 payments from 11 companies in 2025. Trend: 2023 $752 · 2024 $512 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 1 | $122 |
| TG Therapeutics, Inc. | 1 | $121 |
| CSL Behring | 3 | $99 |
| GlaxoSmithKline, LLC. | 4 | $82 |
| Biogen, Inc. | 3 | $62 |
| Grifols USA, LLC | 3 | $57 |
| Janssen Biotech, Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| ARGENX US, INC. | 1 | $21 |
| Genentech USA, Inc. | 1 | $17 |
Products named: LEQEMBI, BRIUMVI, Hizentra, BENLYSTA, Gamunex-C, NUCALA, TREMFYA, Fabhalta.
Industry payments across TX — which companies pay providers there.
